A citation-based method for searching scientific literature

Raghav Chandra, Neeraja Balachandar, Sam Wang, Scott Reznik, Herbert Zeh, Matthew Porembka. Cancer Gene Ther 2021
Times Cited: 15







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20

M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.
Marie Genin, Francois Clement, Antoine Fattaccioli, Martine Raes, Carine Michiels. BMC Cancer 2015
428
20

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis J H Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson,[...]. N Engl J Med 2006
20

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
13

Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Antonio Pellino, Erika Riello, Floriana Nappo, Stefano Brignola, Sabina Murgioni, Selma Ahcene Djaballah, Sara Lonardi, Vittorina Zagonel, Massimo Rugge, Fotios Loupakis,[...]. World J Gastroenterol 2019
53
13


Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
Xiang-Hua Liu, Ming Sun, Feng-Qi Nie, Ying-Bin Ge, Er-Bao Zhang, Dan-Dan Yin, Rong Kong, Rui Xia, Kai-Hua Lu, Jin-Hai Li,[...]. Mol Cancer 2014
740
13

A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
Tuo Ruan, Weizhen Liu, Kaixiong Tao, Chuanqing Wu. Onco Targets Ther 2020
24
13

Epidemiology of gastric cancer: global trends, risk factors and prevention.
Prashanth Rawla, Adam Barsouk. Prz Gastroenterol 2019
537
13

Age-specific trends in incidence of noncardia gastric cancer in US adults.
William F Anderson, M Constanza Camargo, Joseph F Fraumeni, Pelayo Correa, Philip S Rosenberg, Charles S Rabkin. JAMA 2010
316
13

Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Dongbo Li, Hongfei Ji, Xingjian Niu, Lei Yin, Yiran Wang, Yucui Gu, Jinlu Wang, Xiaoping Zhou, Han Zhang, Qingyuan Zhang. Cancer Sci 2020
88
13

The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites.
William F Anderson, Charles S Rabkin, Natalie Turner, Joseph F Fraumeni, Philip S Rosenberg, M Constanza Camargo. J Natl Cancer Inst 2018
107
13

Gastric Tumor Microenvironment.
Armando Rojas, Paulina Araya, Ileana Gonzalez, Erik Morales. Adv Exp Med Biol 2020
29
13


Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
13

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
Jeeyun Lee, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Min Gew Choi, Tae Sung Sohn, Jae Hyung Noh,[...]. J Clin Oncol 2012
513
13

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, György Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae-You Kim,[...]. Lancet Oncol 2014
13

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Annemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, Karolina Sikorska, Pehr Lind, Marianne Nordsmark, Elma Meershoek-Klein Kranenbarg, Henk Boot, Anouk K Trip, H A Maurits Swellengrebel,[...]. Lancet Oncol 2018
257
13

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Charles S Fuchs, Jiri Tomasek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira Dos Santos, Giuseppe Aprile, David R Ferry,[...]. Lancet 2014
13

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Trevor Leong, B Mark Smithers, Karin Haustermans, Michael Michael, Val Gebski, Danielle Miller, John Zalcberg, Alex Boussioutas, Michael Findlay, Rachel L O'Connell,[...]. Ann Surg Oncol 2017
119
13

The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Eva Simon, Diana Petke, Christine Böger, Hans-Michael Behrens, Viktoria Warneke, Matthias Ebert, Christoph Röcken. PLoS One 2012
88
6

Oct-4 is associated with gastric cancer progression and prognosis.
Wen-Li Jiang, Peng-Fei Zhang, Guo-Feng Li, Jian-Hua Dong, Xue-Song Wang, Yuan-Yu Wang. Onco Targets Ther 2016
10
10

The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Nilgün Kapucuoğlu, Kemal Kürşat Bozkurt, Şirin Başpınar, Murat Koçer, Hasan Erol Eroğlu, Raşit Akdeniz, Mehtap Akçil. Pathol Res Pract 2015
23
6

CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
Yushi Yamakawa, Masatoshi Kusuhara, Masanori Terashima, Yusuke Kinugasa, Takashi Sugino, Masato Abe, Toru Mochizuki, Keiichi Hatakeyama, Kenjiro Kami, Ken Yamaguchi. Biomed Res 2017
14
7

Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
Syedeh Elham Norollahi, Fariborz Mansour-Ghanaei, Farahnaz Joukar, Shervin Ghadarjani, Kourosh Mojtahedi, Kaveh Gharaei Nejad, Hossein Hemmati, Faeze Gharibpoor, Roya Khaksar, Ali Akbar Samadani. Biomed Pharmacother 2019
13
7

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.
Anna D Wagner, Florian Lordick, Heike I Grabsch, Masanori Terashima, Mitsumi Terada, Takaki Yoshikawa, Narikazu Boku, Kozo Kataoka, Elizabeth C Smyth, Murielle Mauer,[...]. Eur J Cancer 2020
11
9

CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Li Yiming, Guo Yunshan, Ma Bo, Zang Yu, Wei Tao, Liang Gengfang, Fan Dexian, Cui Shiqian, Jiang Jianli, Tang Juan,[...]. Oncotarget 2015
42
6

A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin.
Diana Pádua, Rita Barros, Ana Luísa Amaral, Patrícia Mesquita, Ana Filipa Freire, Mafalda Sousa, André Filipe Maia, Inês Caiado, Hugo Fernandes, António Pombinho,[...]. Cancers (Basel) 2020
17
6

Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion.
Nobuaki Fujikuni, Hideki Yamamoto, Kazuaki Tanabe, Yutaka Naito, Naoya Sakamoto, Yuka Tanaka, Kazuyoshi Yanagihara, Naohide Oue, Wataru Yasui, Hideki Ohdan. Cancer Sci 2014
29
6

The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma.
Dong-Dong Yang, Bin-Bin Cui, Ling-yu Sun, Hong-qun Zheng, Qi Huang, Jin-Xue Tong, Qi-Fan Zhang. Cell Biochem Biophys 2011
57
6

Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.
Young A Yoo, Myoung Hee Kang, Hyun Joo Lee, Baek-hui Kim, Jong Kuk Park, Hyun Koo Kim, Jun Suk Kim, Sang Cheul Oh. Cancer Res 2011
256
6

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha. Cancer Res Treat 2016
34
6

Prognostic value of sonic hedgehog protein expression in gastric cancer.
Ju-Yeon Kim, Gyung Hyuck Ko, Young-Joon Lee, Woo-Song Ha, Sang-Kyung Choi, Eun-Jung Jung, Chi-Young Jeong, Young-Tae Ju, Sang-Ho Jeong, Soon-Chan Hong. Jpn J Clin Oncol 2012
15
6

CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.
Sibel Bektas, Burak Bahadir, Bulent Hamdi Ucan, Sukru Oguz Ozdamar. Pathol Oncol Res 2010
33
6

CD44(+) CD324(-) expression and prognosis in gastric cancer patients.
Liang Cao, Xiang Hu, Jian Zhang, Pin Liang, Yi Zhang. J Surg Oncol 2014
15
6

Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Dequan Kong, Guoqiang Su, Lang Zha, Hongyu Zhang, Jifeng Xiang, Wei Xu, Yucheng Tang, Ziwei Wang. Med Oncol 2014
39
6


CD44, Sonic Hedgehog, and Gli1 Expression Are Prognostic Biomarkers in Gastric Cancer Patients after Radical Resection.
Chen Jian-Hui, Zhai Er-Tao, Chen Si-Le, Wu Hui, Wu Kai-Ming, Zhang Xin-Hua, Chen Chuang-Qi, Cai Shi-Rong, He Yu-Long. Gastroenterol Res Pract 2016
17
6

Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
Yuta Wakamatsu, Naoya Sakamoto, Htoo Zarni Oo, Yutaka Naito, Naohiro Uraoka, Katsuhiro Anami, Kazuhiro Sentani, Naohide Oue, Wataru Yasui. Pathol Int 2012
140
6

The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.
Diana Pádua, Paula Figueira, Inês Ribeiro, Raquel Almeida, Patrícia Mesquita. Front Cell Dev Biol 2020
15
6


BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
Xiao-Wei Zhang, Ya-Ping Sheng, Qian Li, Wei Qin, You-Wei Lu, Yu-Fan Cheng, Bing-Ya Liu, Feng-Chun Zhang, Jin Li, Goberdhan P Dimri,[...]. Mol Cancer 2010
86
6

Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
Koji Okudela, Tetsukan Woo, Hideaki Mitsui, Michihiko Tajiri, Munetaka Masuda, Kenichi Ohashi. Pathol Int 2012
70
6

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Ji-Wei Yu, Peng Zhang, Ju-Gang Wu, Sheng-Hua Wu, Xiao-Qiang Li, Shi-Ting Wang, Rui-Qi Lu, Xiao-Chun Ni, Bo-Jian Jiang. J Exp Clin Cancer Res 2010
26
6

SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis.
Xin Zhang, Hao Yu, Yongtao Yang, Rong Zhu, Jianying Bai, Zhihong Peng, Yonghong He, Lei Chen, Wensheng Chen, Dianchun Fang,[...]. J Gastrointest Surg 2010
52
6

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.
Vânia Camilo, Rita Barros, Ricardo Celestino, Patrícia Castro, Joana Vieira, Manuel R Teixeira, Fátima Carneiro, João Pinto-de-Sousa, Leonor David, Raquel Almeida. BMC Cancer 2014
29
6

Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells.
Ita Novita Sari, Lan Thi Hanh Phi, Nayoung Jun, Yoseph Toni Wijaya, Sanghyun Lee, Hyog Young Kwon. Cells 2018
81
6

Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Lang Yang, Jun-Feng Xu, Qian Kang, Ai-Qin Li, Peng Jin, Xin Wang, Yu-Qi He, Na Li, Tao Cheng, Jian-Qiu Sheng. PLoS One 2017
9
11

GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway.
Yizhou Yao, Diyuan Zhou, Dongtao Shi, Hui Zhang, Shenghua Zhan, Xinyu Shao, Kang Sun, Liang Sun, Guangting Wu, Kangjun Tian,[...]. Biomed Pharmacother 2019
26
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.